nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALPL—hematologic cancer	0.609	0.878	CbGaD
Fospropofol—ALB—hematologic cancer	0.0845	0.122	CbGaD
Fospropofol—ALPL—Etoposide—Teniposide—hematologic cancer	0.00394	0.783	CbGdCrCtD
Fospropofol—Propofol—UGT1A1—hematologic cancer	0.00316	0.803	CrCbGaD
Fospropofol—ALPL—Gemcitabine—Cytarabine—hematologic cancer	0.00109	0.217	CbGdCrCtD
Fospropofol—ALPL—blood—hematologic cancer	0.00109	0.146	CbGeAlD
Fospropofol—ALPL—lung—hematologic cancer	0.000953	0.128	CbGeAlD
Fospropofol—ALPL—testis—hematologic cancer	0.000899	0.121	CbGeAlD
Fospropofol—Propofol—ALB—hematologic cancer	0.000774	0.197	CrCbGaD
Fospropofol—ALPL—lymph node—hematologic cancer	0.000652	0.0873	CbGeAlD
Fospropofol—GABRG3—testis—hematologic cancer	0.000532	0.0713	CbGeAlD
Fospropofol—GABRD—testis—hematologic cancer	0.000441	0.059	CbGeAlD
Fospropofol—GABRA5—testis—hematologic cancer	0.000409	0.0548	CbGeAlD
Fospropofol—GABRA3—testis—hematologic cancer	0.000381	0.051	CbGeAlD
Fospropofol—GABRB3—gonad—hematologic cancer	0.000331	0.0443	CbGeAlD
Fospropofol—GABRB2—lung—hematologic cancer	0.000329	0.0441	CbGeAlD
Fospropofol—GABRB2—testis—hematologic cancer	0.00031	0.0416	CbGeAlD
Fospropofol—ALB—testis—hematologic cancer	0.000256	0.0344	CbGeAlD
Fospropofol—GABRB3—lung—hematologic cancer	0.000253	0.0339	CbGeAlD
Fospropofol—Cough—Ifosfamide—hematologic cancer	0.00025	0.00129	CcSEcCtD
Fospropofol—Skin disorder—Thiotepa—hematologic cancer	0.000249	0.00128	CcSEcCtD
Fospropofol—Paraesthesia—Bortezomib—hematologic cancer	0.000247	0.00127	CcSEcCtD
Fospropofol—Headache—Busulfan—hematologic cancer	0.000246	0.00127	CcSEcCtD
Fospropofol—Paraesthesia—Bleomycin—hematologic cancer	0.000245	0.00126	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—hematologic cancer	0.000245	0.00126	CcSEcCtD
Fospropofol—Pruritus—Nilotinib—hematologic cancer	0.000244	0.00126	CcSEcCtD
Fospropofol—Nervous system disorder—Thalidomide—hematologic cancer	0.000243	0.00125	CcSEcCtD
Fospropofol—Pruritus—Imatinib—hematologic cancer	0.000243	0.00125	CcSEcCtD
Fospropofol—Vomiting—Procarbazine—hematologic cancer	0.000242	0.00125	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—hematologic cancer	0.000242	0.00125	CcSEcCtD
Fospropofol—Paraesthesia—Vinorelbine—hematologic cancer	0.000241	0.00124	CcSEcCtD
Fospropofol—Skin disorder—Thalidomide—hematologic cancer	0.000241	0.00124	CcSEcCtD
Fospropofol—Headache—Procarbazine—hematologic cancer	0.000239	0.00123	CcSEcCtD
Fospropofol—Pruritus—Cladribine—hematologic cancer	0.000239	0.00123	CcSEcCtD
Fospropofol—GABRB3—testis—hematologic cancer	0.000238	0.0319	CbGeAlD
Fospropofol—Gastrointestinal disorder—Bortezomib—hematologic cancer	0.000238	0.00122	CcSEcCtD
Fospropofol—Vomiting—Bexarotene—hematologic cancer	0.000238	0.00122	CcSEcCtD
Fospropofol—Vomiting—Dasatinib—hematologic cancer	0.000238	0.00122	CcSEcCtD
Fospropofol—Cough—Mitoxantrone—hematologic cancer	0.000237	0.00122	CcSEcCtD
Fospropofol—Cough—Irinotecan—hematologic cancer	0.000237	0.00122	CcSEcCtD
Fospropofol—Vomiting—Fludarabine—hematologic cancer	0.000237	0.00122	CcSEcCtD
Fospropofol—Angiopathy—Etoposide—hematologic cancer	0.000235	0.00121	CcSEcCtD
Fospropofol—Pain—Bortezomib—hematologic cancer	0.000235	0.00121	CcSEcCtD
Fospropofol—Headache—Dasatinib—hematologic cancer	0.000234	0.00121	CcSEcCtD
Fospropofol—Headache—Bexarotene—hematologic cancer	0.000234	0.00121	CcSEcCtD
Fospropofol—Hepatic failure—Epirubicin—hematologic cancer	0.000234	0.00121	CcSEcCtD
Fospropofol—Mediastinal disorder—Etoposide—hematologic cancer	0.000234	0.00121	CcSEcCtD
Fospropofol—Pain—Bleomycin—hematologic cancer	0.000234	0.0012	CcSEcCtD
Fospropofol—Headache—Fludarabine—hematologic cancer	0.000233	0.0012	CcSEcCtD
Fospropofol—Nausea—Busulfan—hematologic cancer	0.000233	0.0012	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Vinorelbine—hematologic cancer	0.000232	0.0012	CcSEcCtD
Fospropofol—Hypotension—Thalidomide—hematologic cancer	0.000232	0.0012	CcSEcCtD
Fospropofol—Nervous system disorder—Alitretinoin—hematologic cancer	0.000232	0.00119	CcSEcCtD
Fospropofol—Cough—Gemcitabine—hematologic cancer	0.000231	0.00119	CcSEcCtD
Fospropofol—Paraesthesia—Thiotepa—hematologic cancer	0.00023	0.00119	CcSEcCtD
Fospropofol—Pain—Vinorelbine—hematologic cancer	0.00023	0.00118	CcSEcCtD
Fospropofol—Skin disorder—Alitretinoin—hematologic cancer	0.000229	0.00118	CcSEcCtD
Fospropofol—Nervous system disorder—Ifosfamide—hematologic cancer	0.000229	0.00118	CcSEcCtD
Fospropofol—Skin disorder—Ifosfamide—hematologic cancer	0.000227	0.00117	CcSEcCtD
Fospropofol—Nausea—Procarbazine—hematologic cancer	0.000226	0.00117	CcSEcCtD
Fospropofol—Vomiting—Chlorambucil—hematologic cancer	0.000224	0.00116	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	0.000224	0.00115	CcSEcCtD
Fospropofol—Nervous system disorder—Vincristine—hematologic cancer	0.000223	0.00115	CcSEcCtD
Fospropofol—Paraesthesia—Thalidomide—hematologic cancer	0.000223	0.00115	CcSEcCtD
Fospropofol—Hypotension—Carmustine—hematologic cancer	0.000223	0.00115	CcSEcCtD
Fospropofol—Nausea—Bexarotene—hematologic cancer	0.000222	0.00114	CcSEcCtD
Fospropofol—Nausea—Dasatinib—hematologic cancer	0.000222	0.00114	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.000222	0.00114	CcSEcCtD
Fospropofol—Nausea—Fludarabine—hematologic cancer	0.000221	0.00114	CcSEcCtD
Fospropofol—Hypotension—Alitretinoin—hematologic cancer	0.000221	0.00114	CcSEcCtD
Fospropofol—Pain—Thiotepa—hematologic cancer	0.000219	0.00113	CcSEcCtD
Fospropofol—Vomiting—Nilotinib—hematologic cancer	0.000219	0.00113	CcSEcCtD
Fospropofol—Vomiting—Imatinib—hematologic cancer	0.000218	0.00112	CcSEcCtD
Fospropofol—Hypotension—Ifosfamide—hematologic cancer	0.000218	0.00112	CcSEcCtD
Fospropofol—Pruritus—Melphalan—hematologic cancer	0.000218	0.00112	CcSEcCtD
Fospropofol—Nervous system disorder—Irinotecan—hematologic cancer	0.000217	0.00112	CcSEcCtD
Fospropofol—Hepatic failure—Doxorubicin—hematologic cancer	0.000216	0.00112	CcSEcCtD
Fospropofol—Headache—Nilotinib—hematologic cancer	0.000216	0.00111	CcSEcCtD
Fospropofol—Skin disorder—Mitoxantrone—hematologic cancer	0.000215	0.00111	CcSEcCtD
Fospropofol—Headache—Imatinib—hematologic cancer	0.000215	0.00111	CcSEcCtD
Fospropofol—Vomiting—Cladribine—hematologic cancer	0.000214	0.0011	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.000214	0.0011	CcSEcCtD
Fospropofol—Paraesthesia—Carmustine—hematologic cancer	0.000214	0.0011	CcSEcCtD
Fospropofol—Hypotension—Vincristine—hematologic cancer	0.000213	0.0011	CcSEcCtD
Fospropofol—Pain—Thalidomide—hematologic cancer	0.000212	0.00109	CcSEcCtD
Fospropofol—Paraesthesia—Alitretinoin—hematologic cancer	0.000212	0.00109	CcSEcCtD
Fospropofol—Nervous system disorder—Gemcitabine—hematologic cancer	0.000212	0.00109	CcSEcCtD
Fospropofol—Pruritus—Lenalidomide—hematologic cancer	0.000212	0.00109	CcSEcCtD
Fospropofol—Headache—Cladribine—hematologic cancer	0.000211	0.00109	CcSEcCtD
Fospropofol—Skin disorder—Gemcitabine—hematologic cancer	0.00021	0.00108	CcSEcCtD
Fospropofol—Nausea—Chlorambucil—hematologic cancer	0.00021	0.00108	CcSEcCtD
Fospropofol—Paraesthesia—Ifosfamide—hematologic cancer	0.00021	0.00108	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	0.000208	0.00107	CcSEcCtD
Fospropofol—Hypotension—Irinotecan—hematologic cancer	0.000207	0.00107	CcSEcCtD
Fospropofol—Hypotension—Mitoxantrone—hematologic cancer	0.000207	0.00107	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Carmustine—hematologic cancer	0.000206	0.00106	CcSEcCtD
Fospropofol—Vomiting—Vinblastine—hematologic cancer	0.000206	0.00106	CcSEcCtD
Fospropofol—GABRA2—lymph node—hematologic cancer	0.000206	0.0275	CbGeAlD
Fospropofol—Nausea—Nilotinib—hematologic cancer	0.000205	0.00106	CcSEcCtD
Fospropofol—Paraesthesia—Vincristine—hematologic cancer	0.000204	0.00105	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000204	0.00105	CcSEcCtD
Fospropofol—Pain—Carmustine—hematologic cancer	0.000204	0.00105	CcSEcCtD
Fospropofol—Nausea—Imatinib—hematologic cancer	0.000204	0.00105	CcSEcCtD
Fospropofol—Headache—Vinblastine—hematologic cancer	0.000203	0.00104	CcSEcCtD
Fospropofol—Pain—Alitretinoin—hematologic cancer	0.000202	0.00104	CcSEcCtD
Fospropofol—Hypotension—Gemcitabine—hematologic cancer	0.000202	0.00104	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.000202	0.00104	CcSEcCtD
Fospropofol—Nausea—Cladribine—hematologic cancer	0.0002	0.00103	CcSEcCtD
Fospropofol—Pain—Ifosfamide—hematologic cancer	0.0002	0.00103	CcSEcCtD
Fospropofol—Paraesthesia—Mitoxantrone—hematologic cancer	0.000199	0.00103	CcSEcCtD
Fospropofol—Paraesthesia—Irinotecan—hematologic cancer	0.000199	0.00103	CcSEcCtD
Fospropofol—Nervous system disorder—Cisplatin—hematologic cancer	0.000197	0.00102	CcSEcCtD
Fospropofol—Cough—Etoposide—hematologic cancer	0.000197	0.00102	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Vincristine—hematologic cancer	0.000196	0.00101	CcSEcCtD
Fospropofol—Vomiting—Melphalan—hematologic cancer	0.000196	0.00101	CcSEcCtD
Fospropofol—Skin disorder—Cisplatin—hematologic cancer	0.000195	0.00101	CcSEcCtD
Fospropofol—Pruritus—Bortezomib—hematologic cancer	0.000195	0.001	CcSEcCtD
Fospropofol—Pain—Vincristine—hematologic cancer	0.000195	0.001	CcSEcCtD
Fospropofol—Paraesthesia—Gemcitabine—hematologic cancer	0.000194	0.000999	CcSEcCtD
Fospropofol—Angiopathy—Dexamethasone—hematologic cancer	0.000194	0.000999	CcSEcCtD
Fospropofol—Angiopathy—Betamethasone—hematologic cancer	0.000194	0.000999	CcSEcCtD
Fospropofol—Pruritus—Bleomycin—hematologic cancer	0.000193	0.000996	CcSEcCtD
Fospropofol—Nausea—Vinblastine—hematologic cancer	0.000192	0.00099	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000191	0.000986	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	0.000191	0.000984	CcSEcCtD
Fospropofol—Vomiting—Lenalidomide—hematologic cancer	0.00019	0.00098	CcSEcCtD
Fospropofol—Pruritus—Vinorelbine—hematologic cancer	0.00019	0.00098	CcSEcCtD
Fospropofol—Pain—Irinotecan—hematologic cancer	0.00019	0.000977	CcSEcCtD
Fospropofol—Pain—Mitoxantrone—hematologic cancer	0.00019	0.000977	CcSEcCtD
Fospropofol—Hypotension—Cisplatin—hematologic cancer	0.000188	0.000969	CcSEcCtD
Fospropofol—Vomiting—Hydroxyurea—hematologic cancer	0.000188	0.000966	CcSEcCtD
Fospropofol—Headache—Lenalidomide—hematologic cancer	0.000187	0.000966	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000186	0.000961	CcSEcCtD
Fospropofol—ALB—lymph node—hematologic cancer	0.000186	0.0249	CbGeAlD
Fospropofol—Headache—Hydroxyurea—hematologic cancer	0.000185	0.000952	CcSEcCtD
Fospropofol—Pain—Gemcitabine—hematologic cancer	0.000185	0.000952	CcSEcCtD
Fospropofol—Nausea—Melphalan—hematologic cancer	0.000183	0.000942	CcSEcCtD
Fospropofol—Pruritus—Thiotepa—hematologic cancer	0.000182	0.000936	CcSEcCtD
Fospropofol—Paraesthesia—Cisplatin—hematologic cancer	0.000181	0.000931	CcSEcCtD
Fospropofol—Skin disorder—Etoposide—hematologic cancer	0.000179	0.000923	CcSEcCtD
Fospropofol—Cough—Triamcinolone—hematologic cancer	0.000179	0.000921	CcSEcCtD
Fospropofol—Nausea—Lenalidomide—hematologic cancer	0.000178	0.000916	CcSEcCtD
Fospropofol—Pruritus—Thalidomide—hematologic cancer	0.000176	0.000905	CcSEcCtD
Fospropofol—Nausea—Hydroxyurea—hematologic cancer	0.000175	0.000903	CcSEcCtD
Fospropofol—Vomiting—Bortezomib—hematologic cancer	0.000175	0.000902	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000174	0.000895	CcSEcCtD
Fospropofol—Vomiting—Bleomycin—hematologic cancer	0.000174	0.000895	CcSEcCtD
Fospropofol—Headache—Bortezomib—hematologic cancer	0.000172	0.000889	CcSEcCtD
Fospropofol—Hypotension—Etoposide—hematologic cancer	0.000172	0.000888	CcSEcCtD
Fospropofol—Pain—Cisplatin—hematologic cancer	0.000172	0.000887	CcSEcCtD
Fospropofol—Vomiting—Vinorelbine—hematologic cancer	0.000171	0.000881	CcSEcCtD
Fospropofol—Angiopathy—Prednisone—hematologic cancer	0.000169	0.00087	CcSEcCtD
Fospropofol—Headache—Vinorelbine—hematologic cancer	0.000168	0.000868	CcSEcCtD
Fospropofol—Pruritus—Alitretinoin—hematologic cancer	0.000167	0.000861	CcSEcCtD
Fospropofol—Paraesthesia—Etoposide—hematologic cancer	0.000166	0.000853	CcSEcCtD
Fospropofol—Pruritus—Ifosfamide—hematologic cancer	0.000165	0.000851	CcSEcCtD
Fospropofol—Nausea—Bortezomib—hematologic cancer	0.000163	0.000843	CcSEcCtD
Fospropofol—Paraesthesia—Prednisolone—hematologic cancer	0.000163	0.000842	CcSEcCtD
Fospropofol—Vomiting—Thiotepa—hematologic cancer	0.000163	0.000841	CcSEcCtD
Fospropofol—Nausea—Bleomycin—hematologic cancer	0.000162	0.000836	CcSEcCtD
Fospropofol—Headache—Thiotepa—hematologic cancer	0.000161	0.000829	CcSEcCtD
Fospropofol—Nausea—Vinorelbine—hematologic cancer	0.00016	0.000823	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000159	0.00082	CcSEcCtD
Fospropofol—Vomiting—Thalidomide—hematologic cancer	0.000158	0.000813	CcSEcCtD
Fospropofol—Pain—Etoposide—hematologic cancer	0.000158	0.000813	CcSEcCtD
Fospropofol—Headache—Thalidomide—hematologic cancer	0.000156	0.000801	CcSEcCtD
Fospropofol—Pain—Prednisolone—hematologic cancer	0.000156	0.000801	CcSEcCtD
Fospropofol—Pruritus—Gemcitabine—hematologic cancer	0.000153	0.000787	CcSEcCtD
Fospropofol—Nausea—Thiotepa—hematologic cancer	0.000152	0.000786	CcSEcCtD
Fospropofol—Vomiting—Carmustine—hematologic cancer	0.000152	0.000781	CcSEcCtD
Fospropofol—Vomiting—Alitretinoin—hematologic cancer	0.00015	0.000774	CcSEcCtD
Fospropofol—Paraesthesia—Triamcinolone—hematologic cancer	0.00015	0.000774	CcSEcCtD
Fospropofol—Headache—Carmustine—hematologic cancer	0.000149	0.00077	CcSEcCtD
Fospropofol—Nervous system disorder—Dexamethasone—hematologic cancer	0.000149	0.000767	CcSEcCtD
Fospropofol—Nervous system disorder—Betamethasone—hematologic cancer	0.000149	0.000767	CcSEcCtD
Fospropofol—Vomiting—Ifosfamide—hematologic cancer	0.000148	0.000765	CcSEcCtD
Fospropofol—Headache—Alitretinoin—hematologic cancer	0.000148	0.000763	CcSEcCtD
Fospropofol—Nausea—Thalidomide—hematologic cancer	0.000147	0.00076	CcSEcCtD
Fospropofol—Vomiting—Vincristine—hematologic cancer	0.000145	0.000746	CcSEcCtD
Fospropofol—Pain—Triamcinolone—hematologic cancer	0.000143	0.000737	CcSEcCtD
Fospropofol—Headache—Vincristine—hematologic cancer	0.000143	0.000735	CcSEcCtD
Fospropofol—Hypotension—Betamethasone—hematologic cancer	0.000142	0.000731	CcSEcCtD
Fospropofol—Hypotension—Dexamethasone—hematologic cancer	0.000142	0.000731	CcSEcCtD
Fospropofol—Nausea—Carmustine—hematologic cancer	0.000142	0.00073	CcSEcCtD
Fospropofol—Angiopathy—Methotrexate—hematologic cancer	0.000141	0.000727	CcSEcCtD
Fospropofol—Vomiting—Mitoxantrone—hematologic cancer	0.000141	0.000726	CcSEcCtD
Fospropofol—Vomiting—Irinotecan—hematologic cancer	0.000141	0.000726	CcSEcCtD
Fospropofol—Nausea—Alitretinoin—hematologic cancer	0.00014	0.000723	CcSEcCtD
Fospropofol—Mediastinal disorder—Methotrexate—hematologic cancer	0.00014	0.000722	CcSEcCtD
Fospropofol—Headache—Mitoxantrone—hematologic cancer	0.000139	0.000716	CcSEcCtD
Fospropofol—Headache—Irinotecan—hematologic cancer	0.000139	0.000716	CcSEcCtD
Fospropofol—Nausea—Ifosfamide—hematologic cancer	0.000139	0.000715	CcSEcCtD
Fospropofol—Vomiting—Gemcitabine—hematologic cancer	0.000137	0.000707	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000137	0.000705	CcSEcCtD
Fospropofol—Paraesthesia—Betamethasone—hematologic cancer	0.000136	0.000702	CcSEcCtD
Fospropofol—Paraesthesia—Dexamethasone—hematologic cancer	0.000136	0.000702	CcSEcCtD
Fospropofol—Headache—Gemcitabine—hematologic cancer	0.000135	0.000697	CcSEcCtD
Fospropofol—Nausea—Vincristine—hematologic cancer	0.000135	0.000697	CcSEcCtD
Fospropofol—Angiopathy—Epirubicin—hematologic cancer	0.000132	0.00068	CcSEcCtD
Fospropofol—Nausea—Mitoxantrone—hematologic cancer	0.000132	0.000679	CcSEcCtD
Fospropofol—Nausea—Irinotecan—hematologic cancer	0.000132	0.000679	CcSEcCtD
Fospropofol—Mediastinal disorder—Epirubicin—hematologic cancer	0.000131	0.000676	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000131	0.000675	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000131	0.000675	CcSEcCtD
Fospropofol—Pruritus—Etoposide—hematologic cancer	0.00013	0.000672	CcSEcCtD
Fospropofol—Pain—Dexamethasone—hematologic cancer	0.00013	0.000669	CcSEcCtD
Fospropofol—Pain—Betamethasone—hematologic cancer	0.00013	0.000669	CcSEcCtD
Fospropofol—Nervous system disorder—Prednisone—hematologic cancer	0.00013	0.000668	CcSEcCtD
Fospropofol—Skin disorder—Prednisone—hematologic cancer	0.000128	0.000661	CcSEcCtD
Fospropofol—Nausea—Gemcitabine—hematologic cancer	0.000128	0.000661	CcSEcCtD
Fospropofol—Vomiting—Cisplatin—hematologic cancer	0.000128	0.000659	CcSEcCtD
Fospropofol—Angiopathy—Doxorubicin—hematologic cancer	0.000122	0.000629	CcSEcCtD
Fospropofol—Mediastinal disorder—Doxorubicin—hematologic cancer	0.000121	0.000625	CcSEcCtD
Fospropofol—Nausea—Cisplatin—hematologic cancer	0.00012	0.000616	CcSEcCtD
Fospropofol—Paraesthesia—Prednisone—hematologic cancer	0.000119	0.000611	CcSEcCtD
Fospropofol—Pruritus—Triamcinolone—hematologic cancer	0.000118	0.00061	CcSEcCtD
Fospropofol—Cough—Methotrexate—hematologic cancer	0.000118	0.000609	CcSEcCtD
Fospropofol—Vomiting—Etoposide—hematologic cancer	0.000117	0.000604	CcSEcCtD
Fospropofol—Headache—Etoposide—hematologic cancer	0.000116	0.000595	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000114	0.00059	CcSEcCtD
Fospropofol—Headache—Prednisolone—hematologic cancer	0.000114	0.000587	CcSEcCtD
Fospropofol—Cough—Epirubicin—hematologic cancer	0.000111	0.000569	CcSEcCtD
Fospropofol—Nausea—Etoposide—hematologic cancer	0.00011	0.000564	CcSEcCtD
Fospropofol—Nervous system disorder—Methotrexate—hematologic cancer	0.000108	0.000558	CcSEcCtD
Fospropofol—Nausea—Prednisolone—hematologic cancer	0.000108	0.000557	CcSEcCtD
Fospropofol—Pruritus—Dexamethasone—hematologic cancer	0.000107	0.000553	CcSEcCtD
Fospropofol—Pruritus—Betamethasone—hematologic cancer	0.000107	0.000553	CcSEcCtD
Fospropofol—Skin disorder—Methotrexate—hematologic cancer	0.000107	0.000553	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000107	0.000552	CcSEcCtD
Fospropofol—Vomiting—Triamcinolone—hematologic cancer	0.000106	0.000548	CcSEcCtD
Fospropofol—Headache—Triamcinolone—hematologic cancer	0.000105	0.00054	CcSEcCtD
Fospropofol—Hypotension—Methotrexate—hematologic cancer	0.000103	0.000532	CcSEcCtD
Fospropofol—Cough—Doxorubicin—hematologic cancer	0.000102	0.000527	CcSEcCtD
Fospropofol—Nervous system disorder—Epirubicin—hematologic cancer	0.000101	0.000522	CcSEcCtD
Fospropofol—Skin disorder—Epirubicin—hematologic cancer	0.0001	0.000517	CcSEcCtD
Fospropofol—Nausea—Triamcinolone—hematologic cancer	9.93e-05	0.000512	CcSEcCtD
Fospropofol—Paraesthesia—Methotrexate—hematologic cancer	9.92e-05	0.000511	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	9.91e-05	0.000511	CcSEcCtD
Fospropofol—Hypotension—Epirubicin—hematologic cancer	9.66e-05	0.000498	CcSEcCtD
Fospropofol—Vomiting—Dexamethasone—hematologic cancer	9.65e-05	0.000497	CcSEcCtD
Fospropofol—Vomiting—Betamethasone—hematologic cancer	9.65e-05	0.000497	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Methotrexate—hematologic cancer	9.53e-05	0.000491	CcSEcCtD
Fospropofol—Headache—Dexamethasone—hematologic cancer	9.51e-05	0.00049	CcSEcCtD
Fospropofol—Headache—Betamethasone—hematologic cancer	9.51e-05	0.00049	CcSEcCtD
Fospropofol—Pain—Methotrexate—hematologic cancer	9.44e-05	0.000487	CcSEcCtD
Fospropofol—Nervous system disorder—Doxorubicin—hematologic cancer	9.38e-05	0.000483	CcSEcCtD
Fospropofol—Pruritus—Prednisone—hematologic cancer	9.35e-05	0.000482	CcSEcCtD
Fospropofol—Skin disorder—Doxorubicin—hematologic cancer	9.29e-05	0.000479	CcSEcCtD
Fospropofol—Paraesthesia—Epirubicin—hematologic cancer	9.28e-05	0.000478	CcSEcCtD
Fospropofol—Nausea—Dexamethasone—hematologic cancer	9.01e-05	0.000464	CcSEcCtD
Fospropofol—Nausea—Betamethasone—hematologic cancer	9.01e-05	0.000464	CcSEcCtD
Fospropofol—Hypotension—Doxorubicin—hematologic cancer	8.94e-05	0.00046	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Epirubicin—hematologic cancer	8.92e-05	0.00046	CcSEcCtD
Fospropofol—Pain—Epirubicin—hematologic cancer	8.84e-05	0.000455	CcSEcCtD
Fospropofol—Paraesthesia—Doxorubicin—hematologic cancer	8.59e-05	0.000443	CcSEcCtD
Fospropofol—Vomiting—Prednisone—hematologic cancer	8.4e-05	0.000433	CcSEcCtD
Fospropofol—Headache—Prednisone—hematologic cancer	8.28e-05	0.000427	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	8.26e-05	0.000425	CcSEcCtD
Fospropofol—Pain—Doxorubicin—hematologic cancer	8.18e-05	0.000421	CcSEcCtD
Fospropofol—Nausea—Prednisone—hematologic cancer	7.85e-05	0.000404	CcSEcCtD
Fospropofol—Pruritus—Methotrexate—hematologic cancer	7.81e-05	0.000403	CcSEcCtD
Fospropofol—Pruritus—Epirubicin—hematologic cancer	7.31e-05	0.000377	CcSEcCtD
Fospropofol—Vomiting—Methotrexate—hematologic cancer	7.02e-05	0.000362	CcSEcCtD
Fospropofol—Headache—Methotrexate—hematologic cancer	6.92e-05	0.000357	CcSEcCtD
Fospropofol—Pruritus—Doxorubicin—hematologic cancer	6.77e-05	0.000349	CcSEcCtD
Fospropofol—Vomiting—Epirubicin—hematologic cancer	6.57e-05	0.000339	CcSEcCtD
Fospropofol—Nausea—Methotrexate—hematologic cancer	6.56e-05	0.000338	CcSEcCtD
Fospropofol—Headache—Epirubicin—hematologic cancer	6.47e-05	0.000334	CcSEcCtD
Fospropofol—Nausea—Epirubicin—hematologic cancer	6.14e-05	0.000316	CcSEcCtD
Fospropofol—Vomiting—Doxorubicin—hematologic cancer	6.08e-05	0.000313	CcSEcCtD
Fospropofol—Headache—Doxorubicin—hematologic cancer	5.99e-05	0.000309	CcSEcCtD
Fospropofol—Nausea—Doxorubicin—hematologic cancer	5.68e-05	0.000293	CcSEcCtD
Fospropofol—GABRA1—Transmission across Chemical Synapses—MDM2—hematologic cancer	2.54e-05	0.000265	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.54e-05	0.000264	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PDGFA—hematologic cancer	2.54e-05	0.000264	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.53e-05	0.000264	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.52e-05	0.000263	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL1B—hematologic cancer	2.52e-05	0.000262	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL3RA—hematologic cancer	2.51e-05	0.000262	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—EP300—hematologic cancer	2.49e-05	0.000259	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—MDM2—hematologic cancer	2.44e-05	0.000254	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.41e-05	0.000251	CbGpPWpGaD
Fospropofol—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	2.37e-05	0.000247	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—MDM2—hematologic cancer	2.37e-05	0.000247	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.37e-05	0.000246	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	2.36e-05	0.000245	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—CREB1—hematologic cancer	2.36e-05	0.000245	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PHYH—hematologic cancer	2.34e-05	0.000244	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GMPS—hematologic cancer	2.34e-05	0.000244	CbGpPWpGaD
Fospropofol—ALB—Metabolism—FTCD—hematologic cancer	2.34e-05	0.000244	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—BRAF—hematologic cancer	2.33e-05	0.000242	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—MDM2—hematologic cancer	2.33e-05	0.000242	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.32e-05	0.000242	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.32e-05	0.000241	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.31e-05	0.00024	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—VEGFA—hematologic cancer	2.3e-05	0.00024	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TNF—hematologic cancer	2.3e-05	0.00024	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—FGR—hematologic cancer	2.3e-05	0.00024	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—H3F3B—hematologic cancer	2.3e-05	0.00024	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—HGF—hematologic cancer	2.3e-05	0.000239	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—MDM2—hematologic cancer	2.29e-05	0.000238	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL6—hematologic cancer	2.28e-05	0.000238	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—CSF2—hematologic cancer	2.27e-05	0.000237	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—MDM2—hematologic cancer	2.27e-05	0.000236	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.26e-05	0.000235	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.24e-05	0.000234	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—MDM2—hematologic cancer	2.23e-05	0.000232	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.22e-05	0.000231	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ITGAL—hematologic cancer	2.21e-05	0.000231	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MYB—hematologic cancer	2.21e-05	0.000231	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.21e-05	0.00023	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.21e-05	0.00023	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.2e-05	0.000229	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PRKCG—hematologic cancer	2.19e-05	0.000228	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—JAK1—hematologic cancer	2.19e-05	0.000228	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—hematologic cancer	2.19e-05	0.000228	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.18e-05	0.000227	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.18e-05	0.000227	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.16e-05	0.000225	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.16e-05	0.000225	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.15e-05	0.000224	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SMPD3—hematologic cancer	2.14e-05	0.000223	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.14e-05	0.000223	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.12e-05	0.000221	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—HRAS—hematologic cancer	2.11e-05	0.00022	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TGFB1—hematologic cancer	2.11e-05	0.00022	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.11e-05	0.00022	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—RAC2—hematologic cancer	2.1e-05	0.000219	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.08e-05	0.000216	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.07e-05	0.000216	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IL2RA—hematologic cancer	2.05e-05	0.000213	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.04e-05	0.000213	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TP53—hematologic cancer	2.03e-05	0.000211	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	2.02e-05	0.00021	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hematologic cancer	2.01e-05	0.00021	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2e-05	0.000208	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PDGFB—hematologic cancer	1.98e-05	0.000206	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—MDM2—hematologic cancer	1.95e-05	0.000203	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.95e-05	0.000203	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.93e-05	0.000201	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.91e-05	0.000199	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SH2B3—hematologic cancer	1.91e-05	0.000198	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.9e-05	0.000198	CbGpPWpGaD
Fospropofol—ALB—Metabolism—B3GAT1—hematologic cancer	1.87e-05	0.000195	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ASNS—hematologic cancer	1.87e-05	0.000195	CbGpPWpGaD
Fospropofol—ALB—Metabolism—DCK—hematologic cancer	1.87e-05	0.000195	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—AKT1—hematologic cancer	1.87e-05	0.000194	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	1.86e-05	0.000193	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL6—hematologic cancer	1.86e-05	0.000193	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.85e-05	0.000192	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	1.84e-05	0.000192	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.83e-05	0.000191	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.83e-05	0.000191	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—TNF—hematologic cancer	1.83e-05	0.00019	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SPARC—hematologic cancer	1.82e-05	0.000189	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.81e-05	0.000188	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.79e-05	0.000187	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.78e-05	0.000186	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HDC—hematologic cancer	1.78e-05	0.000185	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—LCK—hematologic cancer	1.76e-05	0.000183	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.75e-05	0.000182	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.74e-05	0.000181	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.73e-05	0.00018	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—H3F3A—hematologic cancer	1.73e-05	0.00018	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.72e-05	0.000179	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—GATA3—hematologic cancer	1.71e-05	0.000178	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.71e-05	0.000178	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.71e-05	0.000178	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—HSPA5—hematologic cancer	1.7e-05	0.000177	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.7e-05	0.000177	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.69e-05	0.000176	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.69e-05	0.000176	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.69e-05	0.000176	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PRKCZ—hematologic cancer	1.68e-05	0.000175	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.67e-05	0.000173	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.66e-05	0.000172	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.64e-05	0.00017	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.63e-05	0.00017	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.63e-05	0.000169	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CDA—hematologic cancer	1.62e-05	0.000169	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ALB—hematologic cancer	1.6e-05	0.000167	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.6e-05	0.000166	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—HRAS—hematologic cancer	1.59e-05	0.000165	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ALB—hematologic cancer	1.58e-05	0.000164	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—HRAS—hematologic cancer	1.57e-05	0.000163	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—HDAC2—hematologic cancer	1.56e-05	0.000163	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PC—hematologic cancer	1.56e-05	0.000163	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CD44—hematologic cancer	1.55e-05	0.000161	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ITGA4—hematologic cancer	1.55e-05	0.000161	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.54e-05	0.000161	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GBA—hematologic cancer	1.51e-05	0.000157	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC35B2—hematologic cancer	1.51e-05	0.000157	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.51e-05	0.000157	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL3—hematologic cancer	1.51e-05	0.000157	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.5e-05	0.000156	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.5e-05	0.000156	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNA1—hematologic cancer	1.5e-05	0.000156	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PTPN1—hematologic cancer	1.48e-05	0.000154	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—HRAS—hematologic cancer	1.48e-05	0.000154	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.47e-05	0.000154	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.47e-05	0.000153	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—HRAS—hematologic cancer	1.46e-05	0.000152	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—RASGRP1—hematologic cancer	1.46e-05	0.000152	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SYK—hematologic cancer	1.45e-05	0.000151	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.45e-05	0.000151	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.44e-05	0.00015	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.44e-05	0.00015	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.42e-05	0.000148	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.41e-05	0.000147	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.4e-05	0.000146	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.4e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNA2—hematologic cancer	1.39e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTAP—hematologic cancer	1.38e-05	0.000144	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.38e-05	0.000143	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.38e-05	0.000143	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.35e-05	0.000141	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.35e-05	0.00014	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—HRAS—hematologic cancer	1.34e-05	0.000139	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.32e-05	0.000138	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—GRB2—hematologic cancer	1.31e-05	0.000137	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PDGFA—hematologic cancer	1.31e-05	0.000136	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	1.31e-05	0.000136	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—HRAS—hematologic cancer	1.3e-05	0.000135	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—HRAS—hematologic cancer	1.28e-05	0.000133	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.27e-05	0.000132	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ABL1—hematologic cancer	1.26e-05	0.000131	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—HRAS—hematologic cancer	1.25e-05	0.000131	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—HRAS—hematologic cancer	1.25e-05	0.00013	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.23e-05	0.000128	CbGpPWpGaD
Fospropofol—ALB—Metabolism—FHL2—hematologic cancer	1.23e-05	0.000128	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—HRAS—hematologic cancer	1.22e-05	0.000127	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AGRN—hematologic cancer	1.21e-05	0.000126	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.2e-05	0.000125	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—HGF—hematologic cancer	1.18e-05	0.000123	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CSF2—hematologic cancer	1.17e-05	0.000122	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.15e-05	0.00012	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HMMR—hematologic cancer	1.14e-05	0.000119	CbGpPWpGaD
Fospropofol—ALB—Metabolism—IDH2—hematologic cancer	1.14e-05	0.000119	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—JAK1—hematologic cancer	1.13e-05	0.000118	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PRKCG—hematologic cancer	1.13e-05	0.000118	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.08e-05	0.000112	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ARNTL—hematologic cancer	1.08e-05	0.000112	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—HRAS—hematologic cancer	1.07e-05	0.000111	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.06e-05	0.00011	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL2RA—hematologic cancer	1.06e-05	0.00011	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	1.05e-05	0.000109	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CA9—hematologic cancer	1.05e-05	0.000109	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ACP5—hematologic cancer	1.05e-05	0.000109	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NCOR2—hematologic cancer	1.03e-05	0.000108	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	1.02e-05	0.000106	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PDGFB—hematologic cancer	1.02e-05	0.000106	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CDK2—hematologic cancer	9.89e-06	0.000103	CbGpPWpGaD
Fospropofol—ALB—Metabolism—IDH1—hematologic cancer	9.84e-06	0.000102	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTO1—hematologic cancer	9.73e-06	0.000101	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TXN—hematologic cancer	9.73e-06	0.000101	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCC3—hematologic cancer	9.73e-06	0.000101	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	9.66e-06	0.000101	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SPHK1—hematologic cancer	9.52e-06	9.91e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MAPK14—hematologic cancer	9.49e-06	9.88e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	9.37e-06	9.76e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—FN1—hematologic cancer	9.19e-06	9.57e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UGT1A1—hematologic cancer	9.14e-06	9.52e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC22A1—hematologic cancer	8.9e-06	9.26e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CRABP1—hematologic cancer	8.9e-06	9.26e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CG—hematologic cancer	8.8e-06	9.16e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALOX5—hematologic cancer	8.67e-06	9.03e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PTPN11—hematologic cancer	8.64e-06	9e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NUP98—hematologic cancer	8.4e-06	8.74e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CREBBP—hematologic cancer	8.16e-06	8.49e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ADCY7—hematologic cancer	8.15e-06	8.49e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NCOA3—hematologic cancer	8.15e-06	8.49e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NUP214—hematologic cancer	8.09e-06	8.43e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.01e-06	8.34e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	7.97e-06	8.3e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTR—hematologic cancer	7.93e-06	8.26e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCG2—hematologic cancer	7.93e-06	8.26e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ENO2—hematologic cancer	7.78e-06	8.1e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CD—hematologic cancer	7.73e-06	8.05e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTT1—hematologic cancer	7.54e-06	7.85e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.43e-06	7.73e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SDC1—hematologic cancer	7.37e-06	7.68e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3R1—hematologic cancer	7.3e-06	7.61e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—JAK2—hematologic cancer	7.1e-06	7.39e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.06e-06	7.35e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.04e-06	7.33e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CB—hematologic cancer	6.74e-06	7.02e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.65e-06	6.92e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	6.51e-06	6.78e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CD44—hematologic cancer	6.27e-06	6.53e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NQO1—hematologic cancer	6.27e-06	6.53e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL2—hematologic cancer	6.19e-06	6.45e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.14e-06	6.39e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYCS—hematologic cancer	5.93e-06	6.18e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HSP90AA1—hematologic cancer	5.89e-06	6.14e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—EP300—hematologic cancer	5.56e-06	5.79e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SRC—hematologic cancer	5.4e-06	5.63e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.3e-06	5.52e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VEGFA—hematologic cancer	5.26e-06	5.48e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTP1—hematologic cancer	5.23e-06	5.44e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NRAS—hematologic cancer	5.2e-06	5.41e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.06e-06	5.27e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MAPK3—hematologic cancer	4.98e-06	5.18e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCB1—hematologic cancer	4.95e-06	5.15e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB1—hematologic cancer	4.83e-06	5.03e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTM1—hematologic cancer	4.8e-06	5e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NCOR1—hematologic cancer	4.8e-06	5e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—KRAS—hematologic cancer	4.47e-06	4.66e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTHFR—hematologic cancer	4.25e-06	4.42e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CA—hematologic cancer	4.11e-06	4.28e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TP53—hematologic cancer	3.98e-06	4.14e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—HRAS—hematologic cancer	3.8e-06	3.96e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.74e-06	3.9e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CG—hematologic cancer	3.57e-06	3.71e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—AKT1—hematologic cancer	3.36e-06	3.5e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CREBBP—hematologic cancer	3.31e-06	3.44e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CD—hematologic cancer	3.14e-06	3.27e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3R1—hematologic cancer	2.96e-06	3.08e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CB—hematologic cancer	2.73e-06	2.85e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTEN—hematologic cancer	2.36e-06	2.46e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—EP300—hematologic cancer	2.25e-06	2.35e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CA—hematologic cancer	1.67e-06	1.74e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AKT1—hematologic cancer	1.36e-06	1.42e-05	CbGpPWpGaD
